Amgen Inc has reach agreement to take over Onyx Pharmaceuticals Inc for $10.4 billion in cash thereby strengthening its oncology portfolio and acquiring a marketed product for multiple myeloma. The agreement was announced on Sunday. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
